Case Comprehensive Cancer Center, Case Western Reserve University
Cleveland, OH
Curriculum Vitae | ||||||
EDUCATION |
|
|
| |||
2021-present | University Hospitals Cleveland Medical Center | |||||
Radiation Oncology Residency | ||||||
2020-2021 | University of Houston | |||||
| Transitional Year Residency | |||||
2007-2015 | Shahid Beheshti University of Medical Sciences, Iran | |||||
| Doctor of Medicine (Honors) | |||||
HONORS AND AWARDS |
|
| ||||
2015 | Recognized Invention “Ovulation Predictor” | |||||
2014 | Student Teaching Excellence Award | |||||
MANUSCRIPTS UNDER PREPARATION | ||||||
1- Association of insurance status and cervical cancer tumor size in the United States | ||||||
2- Prevalence of periatal mortality due to neoplasia in the United States (2015-2017): An epidemiologic study
| ||||||
PEER-REVIEWED PUBLISHED MANUSCRIPTS | ||||||
1- | Rezaei A, et al | |||||
| Vasa previa: a multicenter retrospective cohort study. | |||||
| Am J Obstet Gynecol. | 2019 Jun 13 | ||||
2- | Rezaei A, et al. | |||||
| Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. | |||||
| Am J Obstet Gynecol. | 2019 Oct;221(4):337. | ||||
3- | Rezaei A, et al. | |||||
| Amnioreduction in cases of polyhydramnios: Indications and outcomes in singleton pregnancies without fetal interventions. | |||||
| Eur J Obstet Gynecol Reprod Biol. | 2019 Oct;241:126-128. | ||||
4- | Rezaei A, et al. | |||||
| Obstetric outcomes of ex-utero intrapartum treatment (EXIT). | |||||
| Prenat Diagn. | 2019 Jul;39(8):643-646. | ||||
5- | Rezaei A, et al. | |||||
| Severe hypocalcemia during surgery for placenta accreta spectrum: The case for empiric replacement. | |||||
| Acta Obstet Gynecol Scand. | 2019 Oct;98(10):1326-1331. | ||||
6- | Rezaei A, et al. | |||||
| Coagulopathy in surgical management of placenta accreta spectrum. | |||||
| Eur J Obstet Gynecol Reprod Biol. | 2019 Jun;237:126-130. | ||||
7- | Rezaei A, et al. | |||||
| Primary fetal pleural effusion: Characteristics, outcomes, and the role of intervention. | |||||
| Prenat Diagn. | 2019 May;39(6):484-488. | ||||
PATENTS | ||||||
| Ovulation Predictor: | IR Patent No 84771; November 01, 2014 | ||||
PROFESSIONAL MEMBERSHIP | ||||||
• American Society of Radiation Oncology |
Disclosures:
Sunday, September 29, 2024
2:45 PM – 4:15 PM ET
Sunday, September 29, 2024
4:45 PM – 6:00 PM ET
3559 - CT and MRI Time Difference on OAR Dose in HDR for Cervical Cancer
Monday, September 30, 2024
8:00 AM – 9:00 AM ET